<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Med | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-06T17:34:20+08:00</updated>
  <subtitle>Best Evidence, Best Benefit</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>全球肿瘤新药重磅临床进展 | 2020年10月</title>
    <updated>2020-11-06T12:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/RqQZYsjgUYp27A9KsQ4wvw</id>
    <link href="https://mp.weixin.qq.com/s/RqQZYsjgUYp27A9KsQ4wvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床研究月报 | 2020年10月</title>
    <updated>2020-11-04T13:45:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/JVK-KnYW-1ajUVFFRp_fSA</id>
    <link href="https://mp.weixin.qq.com/s/JVK-KnYW-1ajUVFFRp_fSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>风云雄霸天下，晚期胃癌一线免疫治疗谁与争锋？</title>
    <updated>2020-11-02T09:43:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/uRpfYIRKSAdDNT-TQA_RlQ</id>
    <link href="https://mp.weixin.qq.com/s/uRpfYIRKSAdDNT-TQA_RlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床试验那些事：I期剂量探索试验中关于药物联合治疗的所思所想</title>
    <updated>2020-10-29T09:27:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/mwepeoPNTKZ_4ApOiC4Q3Q</id>
    <link href="https://mp.weixin.qq.com/s/mwepeoPNTKZ_4ApOiC4Q3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>KRAS抑制剂对比：MRTX849比AMG510更好吗？</title>
    <updated>2020-10-27T12:21:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/P2GToBPxv7_gieXIHJglGQ</id>
    <link href="https://mp.weixin.qq.com/s/P2GToBPxv7_gieXIHJglGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>鉴往知来：李宁教授漫谈罕见肿瘤</title>
    <updated>2020-10-26T10:15:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/wZRxHbsPvH2-E3HxUS0V3w</id>
    <link href="https://mp.weixin.qq.com/s/wZRxHbsPvH2-E3HxUS0V3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10万人，10年随访！胃癌发病率与遗传、健康生活方式关系几何？</title>
    <updated>2020-10-23T11:35:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/aSCLdmKZghbZDty7uQwGrA</id>
    <link href="https://mp.weixin.qq.com/s/aSCLdmKZghbZDty7uQwGrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一文盘点 KEYNOTE 系列研究</title>
    <updated>2020-10-22T10:36:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-22:/s/ZrLPexkLhQwZe6lW7YSsvA</id>
    <link href="https://mp.weixin.qq.com/s/ZrLPexkLhQwZe6lW7YSsvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>朱小东点评：O+Y，晚期肝癌二线治疗的新选择</title>
    <updated>2020-10-21T12:15:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-21:/s/i9S_TPZzIYNY9rmDyazppg</id>
    <link href="https://mp.weixin.qq.com/s/i9S_TPZzIYNY9rmDyazppg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【The Oncologist】姜军教授团队发文：吡咯替尼首项新辅助治疗早期乳腺癌II期研究</title>
    <updated>2020-10-19T12:31:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/a3OdrYnwfO1eLP9FcCT51g</id>
    <link href="https://mp.weixin.qq.com/s/a3OdrYnwfO1eLP9FcCT51g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>